Vaxcyte Says FDA OK's IND Application Of VAX-31 For Prevention Of Invasive Pneumococcal Disease

RTTNews | 687 days ago
Vaxcyte Says FDA OK's IND Application Of VAX-31 For Prevention Of Invasive Pneumococcal Disease

(RTTNews) - Vaccine maker Vaxcyte, Inc. (PCVX) announced Thursday that the U.S. Food and Drug Administration (FDA) has cleared the Company's adult Investigational New Drug (IND) application for VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD).

Vaxcyte expects to initiate the VAX-31 Phase 1/2 clinical study in healthy adults in the fourth quarter of this year and announce topline safety, tolerability and immunogenicity results in the second half of 2024.

The VAX-31 Phase 1/2 study, which will enroll approximately 1,000 adults aged 50 and older, is designed to enable us to understand the clinical potential of VAX-31 to improve upon the standard-of-care for adults by providing a broader-spectrum of protection.

read more
Sensex, Nifty End Choppy Session Little Changed

Sensex, Nifty End Choppy Session Little Changed

Indian shares fluctuated before ending little changed on Friday despite GST reforms optimism and firm cues from global markets amid growing expectations of a Federal Reserve interest-rate cut later this month.
RTTNews | 12h 0min ago
European Shares Inch Higher In Cautious Trade

European Shares Inch Higher In Cautious Trade

European stocks were modestly higher on Friday as investors braced for the key U.S. jobs reading due later in the day and French Prime Minister Francois Bayrou's confidence vote on Monday.
RTTNews | 13h 12min ago
Asian Shares Modestly Higher Before Pivotal US Jobs Report

Asian Shares Modestly Higher Before Pivotal US Jobs Report

Asian stocks eked out modest gains on Friday as weak U.S. labor market data reinforced expectations of a Federal Reserve rate cut later this month and U.S. President Donald Trump signed an executive order officially putting into action the U.S.-Japan trade agreement.
RTTNews | 13h 48min ago
Australian Market Trims Early Gains In Mid-market

Australian Market Trims Early Gains In Mid-market

The benchmark S&P/ASX 200 Index is gaining 30.30 points or 0.34 percent to 8,856.80, after touching a high of 8,880.70 earlier. The broader All Ordinaries Index is up 35.00 points or 0.39 percent to 9,126.40. Australian stocks closed significantly higher on Thursday.
RTTNews | 19h 10min ago
Asian Markets Track Wall Street Higher

Asian Markets Track Wall Street Higher

Asian stock markets are trading mostly higher on Friday, following the broadly positive cues from Wall Street overnight, as some weaker than expected U.S. private sector job growth in the month of August bolstered bets the US Fed will lower interest rates later this month. The markets are pricing in a September rate cut and anticipating at least two reductions this year.
RTTNews | 19h 27min ago